Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Biophytis stock | $6.93

Learn how to easily invest in Biophytis stock.

Biophytis SA

Biophytis SA is a biotechnology business based in the US. Biophytis shares (BPTS) are listed on the NASDAQ and all prices are listed in US Dollars. Biophytis employs 25 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Biophytis

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BPTS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biophytis stock price (NASDAQ: BPTS)

Use our graph to track the performance of BPTS stocks over time.

Biophytis shares at a glance

Information last updated 2021-10-17.
Latest market close$6.93
52-week range$6.90 - $18.50
50-day moving average $8.34
200-day moving average $10.32
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.81

Buy Biophytis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biophytis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biophytis price performance over time

Historical closes compared with the close of $6.93 from 2021-10-19

1 week (2021-10-13) 6.93
1 month (2021-09-20) -12.85%
3 months (2021-07-20) -17.50%
6 months (2021-04-20) -45.09%
1 year (2020-10-16) N/A
2 years (2019-10-16) N/A
3 years (2018-10-16) N/A
5 years (2016-10-16) N/A

Biophytis financials

Gross profit TTM $0
Return on assets TTM -38.83%
Return on equity TTM 0%
Profit margin 0%
Book value $0.68
Market capitalisation $87.1 million

TTM: trailing 12 months

Shorting Biophytis shares

There are currently 1,957 Biophytis shares held short by investors – that's known as Biophytis's "short interest". This figure is 72.6% down from 7,153 last month.

There are a few different ways that this level of interest in shorting Biophytis shares can be evaluated.

Biophytis's "short interest ratio" (SIR)

Biophytis's "short interest ratio" (SIR) is the quantity of Biophytis shares currently shorted divided by the average quantity of Biophytis shares traded daily (recently around 1270.7792207792). Biophytis's SIR currently stands at 1.54. In other words for every 100,000 Biophytis shares traded daily on the market, roughly 1540 shares are currently held short.

To gain some more context, you can compare Biophytis's short interest ratio against those of similar companies.

However Biophytis's short interest can also be evaluated against the total number of Biophytis shares, or, against the total number of tradable Biophytis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biophytis's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Biophytis shares in existence, roughly 0 shares are currently held short) or 0.0002% of the tradable shares (for every 100,000 tradable Biophytis shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Biophytis.

Find out more about how you can short Biophytis stock.

Biophytis share dividends

We're not expecting Biophytis to pay a dividend over the next 12 months.

You may also wish to consider:

Biophytis share price volatility

Over the last 12 months, Biophytis's shares have ranged in value from as little as $6.9 up to $18.5. A popular way to gauge a stock's volatility is its "beta".

BPTS.US volatility(beta: 1.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biophytis's is 1.1142. This would suggest that Biophytis's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Biophytis's beta into context you can compare it against those of similar companies.

Biophytis overview

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France. .

Frequently asked questions

What percentage of Biophytis is owned by institutions?
Currently 2.508% of Biophytis shares are held by institutions.
How many people work for Biophytis?
Latest data suggests 25 work at Biophytis.
When does the fiscal year end for Biophytis?
Biophytis's fiscal year ends in December.
Where is Biophytis based?
Biophytis's address is: Sorbonne University, Paris, France, 75005
What is Biophytis's ISIN number?
Biophytis's international securities identification number is: US09076G1040

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site